Chemomab Therapeutics (CMMB) Free Cash Flow (QoQ) (2018 - 2023)
Chemomab Therapeutics (CMMB) Free Cash Flow (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Chemomab Therapeutics | 13.62 Mn | 3.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28.71% |
| Sep 30, 2023 | 30.21% |
| Jun 30, 2023 | -4.10% |
| Mar 31, 2023 | -23.11% |
| Dec 31, 2022 | -11.99% |
| Sep 30, 2022 | 7.93% |
| Jun 30, 2022 | -52.00% |
| Mar 31, 2022 | -23.02% |
| Dec 31, 2021 | -17.36% |
| Sep 30, 2021 | 54.81% |
| Jun 30, 2021 | -340.51% |
| Mar 31, 2021 | 16.71% |
| Dec 31, 2020 | -68.95% |
| Sep 30, 2020 | -4.66% |
| Jun 30, 2020 | 54.24% |
| Mar 31, 2020 | 58.13% |
| Dec 31, 2019 | -22.09% |
| Sep 30, 2019 | 2.26% |
| Jun 30, 2019 | -17.38% |
| Mar 31, 2019 | 16.37% |